BDNF and Alzheimer disease: Notably, its levels are markedly diminished in the brains of AD patients, resulting in compromised synaptic plasticity and neuronal degeneration.[17] Preclinical studies consistently report reductions in both BDNF mRNA and protein expression in AD animal models,[18] with these deficits in neurotrophic signaling being closely linked to disease initiation.